An international trial will test a combined approach to targeting underrecognized cognitive symptoms of multiple sclerosis (MS), coaching patients on becoming more conscientious with the aim of making them more likely to stick with treatment plans. Difficulties with learning, memory, and related functions are among the symptoms of MS, affecting…
Discussion
Scientists have identified six proteins that could serve as targets for new treatments designed to slow multiple sclerosis (MS) progression. The data showed that one protein, RRM2B, may interact with the approved MS treatment Mavenclad (cladribine), while the other proteins interacted with molecules that are not currently used…
Discussion
On June 17, 2006 — 20 years ago yesterday — I had my closest call as a Special Forces medic, and the first mass casualty situation I was ever involved in. Sometime afterward, a teammate observed, “You didn’t even hesitate! You just ran out on the street and did first-aid…
Discussion
Dear multiple sclerosis (MS): I never asked for you. You arrived quietly, starting when I was 17. It wasn’t like a storm at first. You were more like a snowflake: small, unique, and almost easy to dismiss. They call you a “snowflake disease,” and my condition is definitely…
Discussion
People with multiple sclerosis (MS) who were older than 60 had a low risk of disease flares whether they continued or stopped taking disease-modifying therapies (DMTs), according to a recent study. According to researchers, these data suggest that some older adults with MS may be able to consider…
Get regular updates to your inbox.
